Drugs / GEH200486
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05569278 | Aug → Nov 2022 | — | GE Healthcare | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GEH200486 | “Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers” NCT05569278 ↗ |
| Modality | Diagnostic / imaging agent | “a novel magnetic resonance imaging (MRI) contrast agent” NCT05569278 ↗ |
| Route | Intravenous | “Single administration by intravenous (IV) hand injection without dilution” NCT05569278 ↗ |